{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:36Z","timestamp":1792788816739,"version":"4.5.0"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.3201\/eid2910.230519","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T14:47:23Z","timestamp":1695653243000},"source":"Crossref","is-referenced-by-count":30,"title":["Serotype Distribution and Disease Severity in Adults Hospitalized with <i>Streptococcus pneumoniae<\/i> Infection, Bristol and Bath, UK, 2006\u20122022"],"prefix":"10.3201","volume":"29","author":[{"given":"Catherine","family":"Hyams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Challen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hettle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahin","family":"Amin-Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charli","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Ruffino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rauri","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Malin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Martin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Danon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-1","unstructured":"UK Health Security Agency. Pneumococcal: the green book. Chapter 25. 2022 [cited 2023 Mar 10]. https:\/\/www.gov.uk\/government\/publications\/pneumococcal-the-green-book-chapter-25"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-2","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.vaccine.2019.08.073","article-title":"Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries.","volume":"37","author":"Chan","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/INF.0000000000000279","article-title":"Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts\u2019 children.","volume":"33","author":"Loughlin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease.","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-8","doi-asserted-by":"publisher","first-page":"e0172414","DOI":"10.1371\/journal.pone.0172414","article-title":"Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.","volume":"12","author":"Holubar","year":"2017","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-9","doi-asserted-by":"publisher","first-page":"e019795","DOI":"10.1136\/bmjopen-2017-019795","article-title":"Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.","volume":"8","author":"Temple","year":"2018","journal-title":"BMJ Open"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-10","unstructured":"Centers for Disease Control and Prevention. Pneumococcal disease: surveillance and reporting 2023 [cited 2023 Jun 13]. https:\/\/www.cdc.gov\/pneumococcal\/surveillance.html"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-11","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement.","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-13","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","article-title":"Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England.","volume":"72","author":"Amin-Chowdhury","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-14","first-page":"195","article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity.","volume":"21","author":"Chow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-15","unstructured":"Her Majesty\u2019s Government. Social distancing review. 2021 [cited 2023 Mar 10]. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/999413\/Social-Distancing-Review-Report.pdf"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-16","doi-asserted-by":"publisher","first-page":"e045380","DOI":"10.1136\/bmjopen-2020-045380","article-title":"Impact of COVID-19 social distancing measures on future incidence of invasive pneumococcal disease in England and Wales: a mathematical modelling study.","volume":"11","author":"Choi","year":"2021","journal-title":"BMJ Open"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-17","doi-asserted-by":"publisher","first-page":"104493","DOI":"10.1016\/j.ebiom.2023.104493","article-title":"The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study.","volume":"90","author":"Dagan","year":"2023","journal-title":"EBioMedicine"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-18","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009.","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion.","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-20","doi-asserted-by":"crossref","unstructured":"Ripley BD. Pattern recognition and neural networks. Cambridge: Cambridge University Press; 1996.","DOI":"10.1017\/CBO9780511812651"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-21","doi-asserted-by":"crossref","unstructured":"Loader C. Local regression and likelihood. New York: Springer-Verlag; 1999.","DOI":"10.1007\/b98858"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"SpIDnet group1. Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe.","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/genes10110845","article-title":"Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: a major vaccine evader.","volume":"10","author":"Groves","year":"2019","journal-title":"Genes (Basel)"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-24","doi-asserted-by":"publisher","first-page":"e0208211","DOI":"10.1371\/journal.pone.0208211","article-title":"Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.","volume":"13","author":"Cassiolato","year":"2018","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-25","doi-asserted-by":"publisher","first-page":"e1001839","DOI":"10.1371\/journal.pmed.1001839","article-title":"The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity in high-income countries.","volume":"12","author":"Flasche","year":"2015","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-26","unstructured":"NHS Digital. Childhood vaccination coverage statistics, England. 2021\u201322 [cited 2023 Mar 13]. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-immunisation-statistics\/2021-22"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-27","doi-asserted-by":"publisher","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany.","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-28","doi-asserted-by":"publisher","first-page":"18977","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.","volume":"10","author":"L\u00f8chen","year":"2020","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-29","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/cid\/ciz739","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions, United States.","volume":"70","author":"Ahmed","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-30","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement.","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-31","doi-asserted-by":"publisher","first-page":"643326","DOI":"10.3389\/fcimb.2021.643326","article-title":"Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae.","volume":"11","author":"Sender","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-32","doi-asserted-by":"publisher","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","article-title":"Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.","volume":"12","author":"Weinberger","year":"2015","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-33","doi-asserted-by":"publisher","first-page":"e157124","DOI":"10.1172\/JCI157124","article-title":"Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.","volume":"132","author":"Mitsi","year":"2022","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-34","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-35","doi-asserted-by":"publisher","first-page":"e0255659","DOI":"10.1371\/journal.pone.0255659","article-title":"Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.","volume":"16","author":"Alqahtani","year":"2021","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-36","unstructured":"British Thoracic Society. National adult community acquired pneumonia audit. 2018\/19.| Better lung health for all [cited 2023 Mar 10]. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/clinical-audit\/national-adult-community-acquired-pneumonia-audit-201819\/"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-37","unstructured":"UK Health Security Agency. Surveillance of influenza and other seasonal respiratory viruses in winter 2021 to 2022. September 30, 2022 [cited 2023 Mar 27]"},{"key":"key-10.3201\/eid2910.230519-202308291047-R-2-38","doi-asserted-by":"publisher","first-page":"00223","DOI":"10.1183\/23120541.00223-2019","article-title":"Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?","volume":"6","author":"Hyams","year":"2020","journal-title":"ERJ Open Res"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/10\/23-0519_intro","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:57:28Z","timestamp":1732989448000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/10\/23-0519_intro"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2910.230519","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}